Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features
Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and s...
Saved in:
| Published in: | Genome medicine Vol. 16; no. 1; pp. 35 - 18 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
19.02.2024
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1756-994X, 1756-994X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.
Methods
We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.
Results
In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.
Conclusions
Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. |
|---|---|
| AbstractList | Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.BACKGROUNDExtension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.METHODSWe performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.RESULTSIn each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread.CONCLUSIONSOur results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification. Methods We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants. Results In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees. Conclusions Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. Keywords: Prostate cancer, Cancer evolution, Histopathology, Prostate cancer metastasis, Intra-tumour heterogeneity, Spatial genomic analysis Abstract Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification. Methods We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants. Results In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees. Conclusions Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. BackgroundExtension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification.MethodsWe performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants.ResultsIn each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees.ConclusionsOur results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification. We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants. In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees. Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification. We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants. In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees. Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on tumour evolution in prostate cancer metastasis, the emergence and evolution of cancer clones at this early stage of expansion and spread are poorly understood. We aimed to delineate the routes of evolution and cancer spread within the prostate and to seminal vesicles and lymph nodes, linking these to histological features that are used in diagnostic risk stratification. Methods We performed whole-genome sequencing on 42 prostate cancer samples from the prostate, seminal vesicles and lymph nodes of five treatment-naive patients with locally advanced disease. We spatially mapped the clonal composition of cancer across the prostate and the routes of spread of cancer cells within the prostate and to seminal vesicles and lymph nodes in each individual by analysing a total of > 19,000 copy number corrected single nucleotide variants. Results In each patient, we identified sample locations corresponding to the earliest part of the malignancy. In patient 10, we mapped the spread of cancer from the apex of the prostate to the seminal vesicles and identified specific genomic changes associated with the transformation of adenocarcinoma to amphicrine morphology during this spread. Furthermore, we show that the lymph node metastases in this patient arose from specific cancer clones found at the base of the prostate and the seminal vesicles. In patient 15, we observed increased mutational burden, altered mutational signatures and histological changes associated with whole genome duplication. In all patients in whom histological heterogeneity was observed (4/5), we found that the distinct morphologies were located on separate branches of their respective evolutionary trees. Conclusions Our results link histological transformation with specific genomic alterations and phylogenetic branching. These findings have implications for diagnosis and risk stratification, in addition to providing a rationale for further studies to characterise the genetic changes causally linked to morphological transformation. Our study demonstrates the value of integrating multi-region sequencing with histopathological data to understand tumour evolution and identify mechanisms of prostate cancer spread. |
| ArticleNumber | 35 |
| Audience | Academic |
| Author | Wedge, David C. Rao, Srinivasa Lambert, Adam Alham, Nasullah Khalid Omer, Altan Hamdy, Freddie C. Buffa, Francesca Lovell, Shelagh Lopez, Francisco Tomlinson, Ian Mills, Ian G. Verrill, Clare Lamb, Alastair D. Leslie, Tom Bryant, Richard J. Woodcock, Dan J. Kaya, Zeynep James, Martha Tullis, Iain D. C. Cerundolo, Lucia Hayes, Alicia Niederer, Jane O’Hanlon, Miriam Vojnovic, Boris |
| Author_xml | – sequence: 1 givenname: Srinivasa orcidid: 0000-0003-1889-6530 surname: Rao fullname: Rao, Srinivasa email: Srinivasa.rao@nds.ox.ac.uk organization: Nuffield Department of Surgical Sciences, University of Oxford, Botnar Research Centre – sequence: 2 givenname: Clare surname: Verrill fullname: Verrill, Clare organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 3 givenname: Lucia surname: Cerundolo fullname: Cerundolo, Lucia organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 4 givenname: Nasullah Khalid surname: Alham fullname: Alham, Nasullah Khalid organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 5 givenname: Zeynep surname: Kaya fullname: Kaya, Zeynep organization: Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford – sequence: 6 givenname: Miriam surname: O’Hanlon fullname: O’Hanlon, Miriam organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 7 givenname: Alicia surname: Hayes fullname: Hayes, Alicia organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 8 givenname: Adam surname: Lambert fullname: Lambert, Adam organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 9 givenname: Martha surname: James fullname: James, Martha organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 10 givenname: Iain D. C. surname: Tullis fullname: Tullis, Iain D. C. organization: Department of Oncology, University of Oxford – sequence: 11 givenname: Jane surname: Niederer fullname: Niederer, Jane organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 12 givenname: Shelagh surname: Lovell fullname: Lovell, Shelagh organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 13 givenname: Altan surname: Omer fullname: Omer, Altan organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 14 givenname: Francisco surname: Lopez fullname: Lopez, Francisco organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 15 givenname: Tom surname: Leslie fullname: Leslie, Tom organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 16 givenname: Francesca surname: Buffa fullname: Buffa, Francesca organization: Department of Oncology, University of Oxford – sequence: 17 givenname: Richard J. surname: Bryant fullname: Bryant, Richard J. organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 18 givenname: Alastair D. surname: Lamb fullname: Lamb, Alastair D. organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 19 givenname: Boris surname: Vojnovic fullname: Vojnovic, Boris organization: Department of Oncology, University of Oxford – sequence: 20 givenname: David C. surname: Wedge fullname: Wedge, David C. organization: Manchester Cancer Research Centre, University of Manchester – sequence: 21 givenname: Ian G. surname: Mills fullname: Mills, Ian G. organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 22 givenname: Dan J. surname: Woodcock fullname: Woodcock, Dan J. organization: Nuffield Department of Surgical Sciences, University of Oxford – sequence: 23 givenname: Ian surname: Tomlinson fullname: Tomlinson, Ian organization: Department of Oncology, University of Oxford – sequence: 24 givenname: Freddie C. surname: Hamdy fullname: Hamdy, Freddie C. organization: Nuffield Department of Surgical Sciences, University of Oxford |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38374116$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9U8tu1DAUjVARfcAPsECWkBALUuLEcZwVqioeI1ViAxI7y-PcJK4Se7CdaftrfB03M1M6U6Emizj2OSc35557mhxZZyFJXtPsnFLBPwZaZFWRZjlLM1zm6e2z5IRWJU_rmv062lsfJ6chXGcZZzmrXiTHhSgqRik_Sf4sbPQqXXkXoopGkziNbvIE1m6YonH2AwkRVoEYS0aIaocKKw-qIco2pDchug6sG3FfheC0UTMxEA9rUAM0ZHmH9Aid3xwQ15JxGqJJPXTz-03vBkg3EkAC_J7AamM7cmNiv5VfqYgY1xmtBtKCipOH8DJ53qohwKvd8yz5-eXzj8tv6dX3r4vLi6tU86KOqdIl5byEZa6pEiVn-OuiYEAbDXmba1YzoSotsrpWkLMWRCOoXhZcNaXWtSrOksVWt3HqWq68GZW_k04ZudlwvpPKoykDSCwtA62zmpY10wzqZcs5bWrFqpJlukWtT1ut1bQcASuY3R8ORA9PrOll59aSZqLCi6LC-52Cd-hUiHI0QcMwKAtuCjKvcyHKUlQ5Qt8-gl5jay16haiSi4rzij-gOuyVNLZ1-GE9i8qLSmDCcl7OqPP_oPBuAPuOuWwN7h8Q3u0RegxC7MMuU-EQ-Gbfkn9e3GcUAWIL0BjS4KGV2sRNkrAEM6A1ch4HuR0HieMgN-Mgb5GaP6Leqz9JKrYkDDnGEPyDbU-w_gL-JSLO |
| CitedBy_id | crossref_primary_10_1016_j_pscia_2025_100090 crossref_primary_10_1016_j_radonc_2025_111112 crossref_primary_10_1111_bju_16830 crossref_primary_10_3390_cancers17081256 |
| Cites_doi | 10.1016/j.eururo.2020.09.042 10.1111/his.13330 10.1038/s41592-020-01013-2 10.1210/me.2014-1171 10.1096/fj.201700247RR 10.1038/ncomms1825 10.1186/s13059-016-0893-4 10.1002/0471250953.bi1110s43 10.1038/s41467-021-21615-4 10.1038/s41588-020-0584-7 10.1016/j.juro.2009.08.026 10.1111/his.14214 10.1038/s41585-020-00400-w 10.1186/s13000-016-0478-2 10.1530/ERC-21-0002 10.1038/s41586-022-05023-2 10.1002/pros.24497 10.1101/2023.02.27.530113 10.1136/jclinpath-2012-200923 10.1186/s12885-017-3976-z 10.1038/s41467-020-18843-5 10.1038/nature14347 10.1038/s41586-021-04217-4 10.1186/s12859-023-05489-5 10.1002/cjp2.121 10.1038/s41568-020-0290-x 10.1038/s43018-020-0087-6 10.1038/s41596-020-00437-6 10.1073/pnas.1717139115 10.1080/15384101.2018.1426416 10.1038/s41588-018-0086-z 10.1186/s13073-023-01242-y 10.1172/JCI70354 10.1111/bju.14987 10.1038/s43018-020-0085-8 10.1177/1724600818781296 10.1038/ng.3221 10.1016/j.cell.2018.03.029 10.1093/gigascience/giab008 10.1016/j.eururo.2017.04.034 10.1016/j.humpath.2018.11.016 10.48550/arXiv.1303.3997 10.1136/gutjnl-2019-319866 10.1101/gr.221028.117 10.1038/ng.3315 10.1038/modpathol.2017.164 10.1101/2021.04.16.439912 10.1016/j.cell.2012.04.023 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13073-024-01302-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central (subscription) Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1756-994X |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_fea0ecc091594c4e9bf661d9a47540cf PMC10877771 A783072656 38374116 10_1186_s13073_024_01302_x |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom |
| GeographicLocations_xml | – name: United Kingdom |
| GrantInformation_xml | – fundername: Cancer Research UK grantid: C1380/A18444 funderid: http://dx.doi.org/10.13039/501100000289 – fundername: NIHR Oxford Biomedical Research Centre funderid: http://dx.doi.org/10.13039/501100013373 – fundername: Cancer Research UK grantid: 25812 – fundername: Cancer Research UK grantid: C1380/A18444 – fundername: Cancer Research UK grantid: 28701 – fundername: Cancer Research UK grantid: 18444 – fundername: Cancer Research UK grantid: C1994/A28701 |
| GroupedDBID | --- 0R~ 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACJQM ACUHS ADUKV AENEX AFKRA AFPKN AHBYD AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIAM BBNVY BENPR BHPHI BMC BPHCQ BVXVI C6C CCPQU DIK E3Z EBD EBLON EBS ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR IHW INH INR ITC KQ8 LK8 M1P M7P MK0 M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SBL SOJ TUS UKHRP AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c639t-ac51665eb2c1a8564374834e1dce2f2c4948a7c8099ae24fe8d81cb36ad5cc9a3 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 3 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001166746600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-994X |
| IngestDate | Fri Oct 03 12:23:24 EDT 2025 Tue Nov 04 02:05:46 EST 2025 Thu Oct 02 06:56:47 EDT 2025 Tue Oct 14 14:11:55 EDT 2025 Tue Nov 11 11:12:35 EST 2025 Tue Nov 04 18:29:00 EST 2025 Thu May 22 21:24:49 EDT 2025 Mon Jul 21 05:52:43 EDT 2025 Sat Nov 29 06:05:16 EST 2025 Tue Nov 18 22:49:35 EST 2025 Sat Sep 06 07:28:08 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Prostate cancer metastasis Intra-tumour heterogeneity Spatial genomic analysis Histopathology Prostate cancer Cancer evolution |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c639t-ac51665eb2c1a8564374834e1dce2f2c4948a7c8099ae24fe8d81cb36ad5cc9a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-1889-6530 |
| OpenAccessLink | https://link.springer.com/10.1186/s13073-024-01302-x |
| PMID | 38374116 |
| PQID | 2956876676 |
| PQPubID | 2040231 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_fea0ecc091594c4e9bf661d9a47540cf pubmedcentral_primary_oai_pubmedcentral_nih_gov_10877771 proquest_miscellaneous_2928855872 proquest_journals_2956876676 gale_infotracmisc_A783072656 gale_infotracacademiconefile_A783072656 gale_healthsolutions_A783072656 pubmed_primary_38374116 crossref_citationtrail_10_1186_s13073_024_01302_x crossref_primary_10_1186_s13073_024_01302_x springer_journals_10_1186_s13073_024_01302_x |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-19 |
| PublicationDateYYYYMMDD | 2024-02-19 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-19 day: 19 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Genome medicine |
| PublicationTitleAbbrev | Genome Med |
| PublicationTitleAlternate | Genome Med |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | DJ Woodcock (1302_CR11) 2020; 11 RJ Bryant (1302_CR5) 2020; 125 S Bellur (1302_CR40) 2019; 85 L Zheng (1302_CR46) 2012; 3 1302_CR34 J Ren (1302_CR44) 2018; 17 S Nik-Zainal (1302_CR24) 2012; 149 J Gordetsky (1302_CR1) 2016; 11 P Danecek (1302_CR22) 2021; 10 R Böttcher (1302_CR50) 2018; 18 R Core Team (1302_CR32) 2022 GJLH van Leenders (1302_CR3) 2020; 77 GA Van der Auwera (1302_CR23) 2013; 43 R Montironi (1302_CR2) 2018; 33 MLK Chua (1302_CR51) 2017; 72 S López (1302_CR43) 2020; 52 JA Wala (1302_CR30) 2018; 28 D Wangsa (1302_CR45) 2018; 32 PS Gill (1302_CR17) 2012; 65 A Erickson (1302_CR52) 2022; 608 N Mottet (1302_CR39) 2021; 79 L Brady (1302_CR7) 2021; 12 P Ellis (1302_CR18) 2021; 16 F Pedregosa (1302_CR26) 2011; 12 1302_CR15 M Tarabichi (1302_CR27) 2021; 18 S Prendeville (1302_CR37) 2017; 71 1302_CR12 1302_CR56 1302_CR55 A Nurminen (1302_CR14) 2023; 15 MC Haffner (1302_CR47) 2013; 123 T Zhao (1302_CR13) 2022; 601 G Gundem (1302_CR10) 2015; 520 DC Wedge (1302_CR9) 2018; 50 1302_CR19 P Mobadersany (1302_CR49) 2018; 115 K Sirinukunwattana (1302_CR48) 2021; 70 JN Kather (1302_CR16) 2020; 1 SW Fine (1302_CR38) 2018; 31 1302_CR21 1302_CR20 M Robinson (1302_CR35) 2019; 5 JL Wright (1302_CR4) 2009; 182 V Hafstað (1302_CR31) 2023; 24 SMG Espiritu (1302_CR54) 2018; 173 G Van Rossum (1302_CR33) 2009 LS Graham (1302_CR42) 2023 MP Labrecque (1302_CR41) 2021; 28 CS Cooper (1302_CR8) 2015; 47 DPClust pre-processing (1302_CR25) 2022 K Takayama (1302_CR36) 2014; 28 PC Boutros (1302_CR53) 2015; 47 1302_CR28 MC Haffner (1302_CR6) 2021; 18 R Rosenthal (1302_CR29) 2016; 17 |
| References_xml | – ident: 1302_CR20 – volume-title: Wedge lab year: 2022 ident: 1302_CR25 – volume: 79 start-page: 243 year: 2021 ident: 1302_CR39 publication-title: Eur Urol doi: 10.1016/j.eururo.2020.09.042 – volume: 71 start-page: 926 year: 2017 ident: 1302_CR37 publication-title: Histopathology doi: 10.1111/his.13330 – volume: 18 start-page: 144 year: 2021 ident: 1302_CR27 publication-title: Nat Methods doi: 10.1038/s41592-020-01013-2 – volume: 28 start-page: 2012 year: 2014 ident: 1302_CR36 publication-title: Mol Endocrinol doi: 10.1210/me.2014-1171 – volume: 32 start-page: 3502 year: 2018 ident: 1302_CR45 publication-title: FASEB J doi: 10.1096/fj.201700247RR – volume: 3 start-page: 815 year: 2012 ident: 1302_CR46 publication-title: Nat Commun doi: 10.1038/ncomms1825 – ident: 1302_CR28 – volume: 17 start-page: 31 year: 2016 ident: 1302_CR29 publication-title: Genome Biol doi: 10.1186/s13059-016-0893-4 – volume: 43 start-page: 11.10.1 year: 2013 ident: 1302_CR23 publication-title: Curr. Protoc. Bioinforma. doi: 10.1002/0471250953.bi1110s43 – volume: 12 start-page: 1426 year: 2021 ident: 1302_CR7 publication-title: Nat Commun doi: 10.1038/s41467-021-21615-4 – volume: 52 start-page: 283 year: 2020 ident: 1302_CR43 publication-title: Nat Genet doi: 10.1038/s41588-020-0584-7 – volume: 182 start-page: 2702 year: 2009 ident: 1302_CR4 publication-title: J Urol doi: 10.1016/j.juro.2009.08.026 – volume: 77 start-page: 850 year: 2020 ident: 1302_CR3 publication-title: Histopathology doi: 10.1111/his.14214 – volume: 18 start-page: 79 year: 2021 ident: 1302_CR6 publication-title: Nat Rev Urol doi: 10.1038/s41585-020-00400-w – volume: 11 start-page: 25 year: 2016 ident: 1302_CR1 publication-title: Diagn Pathol doi: 10.1186/s13000-016-0478-2 – volume: 28 start-page: T51 year: 2021 ident: 1302_CR41 publication-title: Endocr Relat Cancer doi: 10.1530/ERC-21-0002 – volume: 608 start-page: 360 year: 2022 ident: 1302_CR52 publication-title: Nature doi: 10.1038/s41586-022-05023-2 – year: 2023 ident: 1302_CR42 publication-title: Prostate doi: 10.1002/pros.24497 – ident: 1302_CR55 doi: 10.1101/2023.02.27.530113 – volume: 65 start-page: 1057 year: 2012 ident: 1302_CR17 publication-title: J Clin Pathol doi: 10.1136/jclinpath-2012-200923 – volume: 18 start-page: 8 year: 2018 ident: 1302_CR50 publication-title: BMC Cancer doi: 10.1186/s12885-017-3976-z – volume: 11 start-page: 5070 year: 2020 ident: 1302_CR11 publication-title: Nat Commun doi: 10.1038/s41467-020-18843-5 – volume: 520 start-page: 353 year: 2015 ident: 1302_CR10 publication-title: Nature doi: 10.1038/nature14347 – volume: 601 start-page: 85 year: 2022 ident: 1302_CR13 publication-title: Nature doi: 10.1038/s41586-021-04217-4 – volume-title: Python 3 Reference Manual year: 2009 ident: 1302_CR33 – volume: 24 start-page: 359 year: 2023 ident: 1302_CR31 publication-title: BMC Bioinformatics doi: 10.1186/s12859-023-05489-5 – volume: 5 start-page: 91 year: 2019 ident: 1302_CR35 publication-title: J Pathol Clin Res doi: 10.1002/cjp2.121 – ident: 1302_CR34 doi: 10.1038/s41568-020-0290-x – volume: 1 start-page: 789 year: 2020 ident: 1302_CR16 publication-title: Nat Cancer doi: 10.1038/s43018-020-0087-6 – volume: 16 start-page: 841 year: 2021 ident: 1302_CR18 publication-title: Nat Protoc doi: 10.1038/s41596-020-00437-6 – volume: 115 start-page: E2970 year: 2018 ident: 1302_CR49 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.1717139115 – volume: 17 start-page: 780 year: 2018 ident: 1302_CR44 publication-title: Cell Cycle doi: 10.1080/15384101.2018.1426416 – volume: 50 start-page: 682 year: 2018 ident: 1302_CR9 publication-title: Nat Genet doi: 10.1038/s41588-018-0086-z – volume: 15 start-page: 82 year: 2023 ident: 1302_CR14 publication-title: Genome Med doi: 10.1186/s13073-023-01242-y – volume: 123 start-page: 4918 year: 2013 ident: 1302_CR47 publication-title: J Clin Invest doi: 10.1172/JCI70354 – volume: 12 start-page: 2825 year: 2011 ident: 1302_CR26 publication-title: J Mach Learn Res – ident: 1302_CR19 – volume: 125 start-page: 506 year: 2020 ident: 1302_CR5 publication-title: BJU Int doi: 10.1111/bju.14987 – volume-title: R: a language and environment for statistical computing year: 2022 ident: 1302_CR32 – ident: 1302_CR15 doi: 10.1038/s43018-020-0085-8 – volume: 33 start-page: 331 year: 2018 ident: 1302_CR2 publication-title: Int J Biol Markers doi: 10.1177/1724600818781296 – volume: 47 start-page: 367 year: 2015 ident: 1302_CR8 publication-title: Nat Genet doi: 10.1038/ng.3221 – volume: 173 start-page: 1003 year: 2018 ident: 1302_CR54 publication-title: Cell doi: 10.1016/j.cell.2018.03.029 – volume: 10 start-page: giab008 year: 2021 ident: 1302_CR22 publication-title: GigaScience. doi: 10.1093/gigascience/giab008 – volume: 72 start-page: 665 year: 2017 ident: 1302_CR51 publication-title: Eur Urol doi: 10.1016/j.eururo.2017.04.034 – ident: 1302_CR56 – volume: 85 start-page: 313 year: 2019 ident: 1302_CR40 publication-title: Hum Pathol doi: 10.1016/j.humpath.2018.11.016 – ident: 1302_CR21 doi: 10.48550/arXiv.1303.3997 – volume: 70 start-page: 544 year: 2021 ident: 1302_CR48 publication-title: Gut doi: 10.1136/gutjnl-2019-319866 – volume: 28 start-page: 581 year: 2018 ident: 1302_CR30 publication-title: Genome Res doi: 10.1101/gr.221028.117 – volume: 47 start-page: 736 year: 2015 ident: 1302_CR53 publication-title: Nat Genet doi: 10.1038/ng.3315 – volume: 31 start-page: 122 year: 2018 ident: 1302_CR38 publication-title: Mod Pathol doi: 10.1038/modpathol.2017.164 – ident: 1302_CR12 doi: 10.1101/2021.04.16.439912 – volume: 149 start-page: 994 year: 2012 ident: 1302_CR24 publication-title: Cell doi: 10.1016/j.cell.2012.04.023 |
| SSID | ssj0064247 |
| Score | 2.3699338 |
| Snippet | Background
Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant... Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant research on... Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant... BackgroundExtension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite significant... Abstract Background Extension of prostate cancer beyond the primary site by local invasion or nodal metastasis is associated with poor prognosis. Despite... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 35 |
| SubjectTerms | Adenocarcinoma Biobanks Bioinformatics Biomedical and Life Sciences Biomedicine Cancer Cancer evolution Cancer Research Care and treatment Copy number DNA sequencing Evolution Genetic aspects Genetic testing Genetic transformation Genome instability in cancer: from mechanisms to the clinic Genomes Genomics Histopathology Human Genetics Humans Intra-tumour heterogeneity Lymph nodes Lymphatic Metastasis - pathology Lymphatic system Male Malignancy Medical prognosis Medicine/Public Health Metabolomics Metastases Metastasis Mutation Nucleotide sequencing Patients Phylogeny Prostate - pathology Prostate cancer Prostate cancer metastasis Prostatic Neoplasms - genetics Prostatic Neoplasms - pathology Seminal vesicle Seminal Vesicles - pathology Spatial genomic analysis Systems Biology Tumors Vesicles Whole genome sequencing |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Pj9UgECdmo4kX43-rq2Ji4sElK5QCPa7GjSZm40GTvRFKIb7E7Xt57Vt3v5qfzhlo327XqBePLQMtzDAzwPAbQl7y2ou2lXjkbyKTvoYpVfKSyapB-D3fNDFlLfmkj47M8XH9-VKqL4wJy_DAeeD2Y3Bv4DNg1qpaehnqJoJJaWsnNTgbPqL2Ba9nWkxlHQxOtdTTFRmj9nuOoszAHrF0UsfOZmYoofX_rpMvGaWrAZNXTk2TMTq8TW6NXiQ9yH9_h1wL3V1yI-eVPL9Hfn7EBtgKb3QgIisdNrDCX9NwOgraHgXmrnq66OhJGNxIBV8DjlPXtTTBECN-6wm8dxcs7ClCPkEHWtqc0wlrAgroMtIUnMgw1QM8_8DEuyw1EegYsA19objxm5vHZMiT6qXAADzL6O-Tr4fvv7z7wMYkDcyDczMw5yuuVAULdM-dqfAcEPcnA4fBElF4hJ9x2hvwRF0QMgbTGu6bUrm28r525QOy0y278IjQWJel46ZVSrcyKuFCo4LS0ZhGuaCqgvCJZ9aPCOaYSOO7TSsZo2zmswU-28Rne1aQ19s6q4zf8VfqtygKW0rE3k4vQCLtKJH2XxJZkOcoSDZfZN1qEHugDXxPgANdkFeJAnUIdMC78SoEDAOicc0od2eUMPf9vHgSVjvqnt4KvAGqMXa5IC-2xVgT4-m6sNwgjTCmqowWBXmYZXvbadyzkJxDbTOT-tmozEu6xbeETM4TvKTmBdmbJsjFf_152B__j2F_Qm6KNMEF4_Uu2RnWm_CUXPenw6JfP0vq4RcU2G6x priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central (subscription) dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELegA2kvfH8EBhgJiQdmDTtO4jyhDW0CCVUTAmlvluPYUImmXdOO7V_jr-POcVoyxF54bHxO48vvzhf7_DtCXvHSirqWuOWvPJO2BJNKecpkViH9nq0qH6qWfCrGY3VyUh7HBbc2plX2PjE46npmcY18T-C5tgIzMt_NTxlWjcLd1VhC4zrZQqYyOSJbB4fj48-9L4bgWhb9URmV77UcIc1gXmJhx46dD6ajwNr_t2_-Y3K6nDh5afc0TEpHt_93OHfIrRiO0v0OP3fJNdfcIze7ApUX98mvj_gEbI5HQ5DalS5XU-hC3VlE7C4FlMxbOmno1C1NlILHBehQ09Q08BkjEewUrpsNFlqK3FGggZpWF7QnrYAGOvM0ZDkyrBkBv39iBV8WbuFozPwGZVBcQe5uj1WVex9OvQtUpe0D8vXo8Mv7DyxWe2AWoqQlMzbjeZ7Bl77lRmW4oYgLnY6DtoUXFnlsTGEVhLTGCemdqhW3VZqbOrO2NOlDMmpmjXtMqC_T1HBVg3pr6XNhXJW7vPBKVblxeZYQ3r90bSMVOlbk-KHDJ5HKdQcUDUDRASj6PCFv1n3mHRHIldIHiKW1JJJ4hwuzxTcdfYIGhbwFC4KILSulla6sPERLdWlkAXG09Ql5gUjU3YnYtSvS-4WC_xMQiSfkdZBAZwQDsCaeqQA1IK3XQHJnIAlOxA6be5jq6MRavcFoQl6um7EnJuY1brZCGaFUlqlCJORRZxzrQePih-QcequB2Qy0MmxpJt8DxTkPPJUFT8hub2Gb5_q32p9cPYynZFsE2xeMlztktFys3DNyw54tJ-3iefQdvwFiPn1x priority: 102 providerName: ProQuest |
| Title | Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features |
| URI | https://link.springer.com/article/10.1186/s13073-024-01302-x https://www.ncbi.nlm.nih.gov/pubmed/38374116 https://www.proquest.com/docview/2956876676 https://www.proquest.com/docview/2928855872 https://pubmed.ncbi.nlm.nih.gov/PMC10877771 https://doaj.org/article/fea0ecc091594c4e9bf661d9a47540cf |
| Volume | 16 |
| WOSCitedRecordID | wos001166746600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: RBZ dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: M7P dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink Journals customDbUrl: eissn: 1756-994X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0064247 issn: 1756-994X databaseCode: RSV dateStart: 20090101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagBYkX7iNQFiMh8UAtcA7beWxRKyrBalUOLU-W49iwEptdbbKF_jV-HTNOsiXlkOAlUuxxEtsz44k98w0hT3hu47JM8chfeZbaHEQq4QlLswLh92xR-JC15LUcj9V0mk-6oLC693bvjySDpg5ircTzmiM7MlhTWDhtY2A5bsNyp1Acj99-6PUvGNSp7MNjfttusAQFpP5f9fFPC9J5Z8lzJ6ZhITq89n9duE6udoYn3Ws55Qa54Kqb5HKbivL0Fvl-hO9lSwwCQRBX2qzn0IS6k443dynww7Kms4rOXWM6KvgAYBJqqpIG5GKEfJ1DuTmb9ZoiShT0u6TFKe3hKaCCLjwN_owMs0PA_VfM1cvCIxztfLyhexT3itvHY_7kXltT7wIoaX2bvD88ePfyFevyOjAL9lDDjM24EBn801tuVIZHh7il6TiMcexji4g1RloFxqtxceqdKhW3RSJMmVmbm-QO2aoWlbtHqM-TxHBVCiHL1IvYuEI4Ib1ShTBOZBHh_VRr24GeY-6NLzr8_Cih2znRMCc6zIn-FpFnmzbLFvLjr9T7yEEbSoTrDgWL1SfdSb-GAXkBsgK2WZanNnV54cEuKnOTSrCYrY_II-Q_3ca-bpSO3pMK3heDzR2Rp4EC1Q50wJouegKGAQG8BpQ7A0pQF3ZY3fO47tRVrWMMGpXo7hyRx5tqbIkueJVbrJEmVirLlIwjcrcViU2ncZsj5Rxaq4GwDEZlWFPNPgcwcx4QKSWPyG4vM2ff9edhv_9v5A_IlTiIXcx4vkO2mtXaPSSX7Ekzq1cjclFOZbiqEdnePxhPjkdhc2aErsATKJscvZl8HAU98wOiC3mg |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKAcGF92OhUCOBOFCr2PvyHhAqj6pRQ8ShSLm5Xq-3jUQ2IZu0zZ_iB_DrmPE-whbRWw8csx4769l5eOzxN4S85IkRWRbgkb_MWWASUCmf-ywIU4TfM2mau6ol_XgwkMNh8nWN_GzuwmBaZWMTnaHOJgb3yLcF3muLMSPz_fQHw6pReLralNCoxGLfLk8hZCvf9T7B930lxO7ng497rK4qwAx44znTJuRRFEJEabiWIR5c4Yaa5ZmxIhcG8VJ0bCQsnbQVQW5lJrlJ_UhnoTGJ9mHcK-Qq2PEYU8jiYRvgwVI-iJuLOTLaLjkqEAMvyNz5IDvrOD9XI-BvT_CHKzyfpnnurNa5wN3b_xvz7pBb9WKb7lTacZes2eIeuV6V31zeJ796OGM2xYsvCFxL54sxdKH2pNbHLQo6MC3pqKBjO9c1FbAHFIPqIqMOrRlhbsfwXK8kvaSIjAUcz2i6pA0kBzTQSU5dDifDihjw-xTrEzM3hKV1Xjswn-L-eDU81oxuPBTNrQNiLR-Qb5fCuIdkvZgU9jGheeL7mssMPmcW5JHQNo1sFOdSppG2UegR3giZMjXQO9Yb-a5cwCcjVQmmAsFUTjDVmUfetH2mFczJhdQfUHZbSoQodw8msyNVWzwFDHkL9gHWo2ESmMAmaQ5rwSzRQQxRgsk9somSr6r7vq2hVTuxhP8TEGd45LWjQFMLEzC6vjECbEDQsg7lRocSTKTpNjdqoWoTXaqVTnjkRduMPTHtsLCTBdIIKcNQxsIjjyplbCeNWzsB59BbdtS0w5VuSzE6dgDu3KFwxtwjW41Gr97r32x_cvE0NsmNvYMvfdXvDfafkpvC2R3BeLJB1uezhX1GrpmT-aicPXdWi5LDy9b039WX2f4 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELZQOcQL9xEo1EhIPFCr2HEc57EcFRXVqhKH-mY5jg0rsdnVJlvoX-PXMeMk26YcEuJx43HWHs-Mx_HMN4Q85YUTVSXxyl8HJl0BKpXylMmsRPg9V5YhVi05yCcTfXRUHJ7J4o_R7sOVZJfTgChNdbuzqEKn4lrtNBxFk8H-wuLNGwMv8qLEokF4Xn__abDF4FzLfEiV-W2_0XYUUft_tc1nNqfzgZPnbk_jprR3_f-nc4Nc6x1SuttJ0E1ywde3yOWuROXJbfJjH8fAFpgcguCutF3NoAv1x73MblOQk0VDpzWd-db2VDAYEB5q64pGRGOEgp3Bc3sqDQ1F9CjgQUXLEzrAVkADnQca4xwZVo2A39-whi-Lr_C0j_2GqVL8hty9HusqD1acBh_BSps75OPemw-v3rK-3gNz4Ce1zLqMK5XBWd9xqzO8UsRPnZ4Dv0UQDpFsbO40OLXWCxm8rjR3ZapslTlX2PQu2ajntb9PaCjS1HJdKZVXMihhfam8yoPWpbJeZQnhw7Ib14OhY02OryYeirQy3ZoYWBMT18R8T8jzdZ9FBwXyV-qXKE1rSoTxjg_my8-mtwoGGPICdAh8tqyQTvqiDOAvVYWVOXjSLiRkC2XRdDmxa2NkdnMN_yfAF0_Is0iB5ggm4GyfVQFsQGCvEeXmiBLMiBs3D_JuejPWGIHJpDmGQSfkyboZe2JoXu3nK6QRWmeZzkVC7nXqsZ40fv6QnENvPVKcEVfGLfX0SwQ55xGpMucJ2R7053Rcf2b7g38j3yJXDl_vmYP9ybuH5KqIGigYLzbJRrtc-Ufkkjtup83ycTQrPwGVc35j |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intra-prostatic+tumour+evolution%2C+steps+in+metastatic+spread+and+histogenomic+associations+revealed+by+integration+of+multi-region+whole-genome+sequencing+with+histopathological+features&rft.jtitle=Genome+medicine&rft.au=Rao%2C+Srinivasa&rft.au=Verrill%2C+Clare&rft.au=Cerundolo%2C+Lucia&rft.au=Alham%2C+Nasullah+Khalid&rft.date=2024-02-19&rft.pub=BioMed+Central&rft.eissn=1756-994X&rft.volume=16&rft_id=info:doi/10.1186%2Fs13073-024-01302-x&rft.externalDocID=PMC10877771 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-994X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-994X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-994X&client=summon |